The high toxicity of most chemotherapeutic drugs and their inactivation by multidrug resistance phenotypes motivated extensive search for drugs with new modes of action. We designed a short cationic diastereomeric peptide composed of D-and L-leucines, lysines, and arginines that has selective toxicity toward cancer cells and significantly inhibits lung metastasis formation in mice (86%) with no detectable side effects. Its ability to depolarize the transmembrane potential of cancer cells at the same rate (within minutes) and concentration (3 M), at which it shows biological activity, suggests a killing mechanism that involves plasma membrane perturbation. Confocal microscopy experiments verified that the cells died as a result of acute injury, swelling, and bursting, suggesting necrosis. Biosensor binding experiments and attenuated total reflectance-Fourier transform infrared spectroscopy using model membranes have substantiated its high selectivity toward cancer cells. Although this is an initial study that looked at tumor formation rather than the ability of the peptides to reduce established tumors, the simple sequence of the peptide, its high solubility, substantial resistance to degradation, and inactivation by serum components might make it a good candidate for future anticancer treatment.Current anticancer chemotherapies that are based on alkylating agents, antimetabolites, and natural products respond incompletely; this is probably related to the development of drug resistance. Most chemotherapeutic agents also affect normal cells and consequently cause severe side effects (1). Thus, there is an urgent need to develop new classes of anticancer drugs with new modes of action that selectively target the cancer cells. A promising group under investigation includes cationic antimicrobial peptides, which are known to play an important role in the innate immunity of a diverse range of organisms, including insects, amphibians, and mammals (2). Most of these peptides have an amphipathic structure, and they preferentially bind and insert into negatively charged cell membranes. Consequently, destabilization of the membrane disturbs the electrolyte balance and induces the intracellular contents to leak, leading to cell death. In contrast to normal eukaryotic cells, which generally have low membrane potentials and whose outer leaflet almost exclusively consists of zwitterionic phospholipids, the prokaryotic and cancer cell membranes maintain large transmembrane potentials and have a higher content of anionic phospholipids on their outer leaflet. Many antimicrobial peptides therefore preferentially disrupt prokaryotic and cancer cell membranes rather than eukaryotic membranes (3).Several in vitro studies were conducted with native all L-amino acid antimicrobial peptides with defined ␣-helical or -sheet secondary structures (3). However, the use of native antimicrobial peptides in vivo is mainly limited due to the loss of their function in serum, partially because of enzymatic degradation and binding to serum compone...